Retour
Fourchette du Jour
20,94 €
21,51 €
Fourchette 52 Semaines
13,40 €
28,35 €
Volume
1 255 209
Moyenne 50J / 200J
24,03 €
/
23,75 €
Clôture Précédente
20,74 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 9,2 | 0,4 |
| P/B | 2,9 | 2,9 |
| ROE % | 39,9 | 3,8 |
| Net Margin % | 36,5 | 3,9 |
| Rev Growth 5Y % | 22,0 | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
34,20 €
+62.9%
Low: 29,00 €
High: 40,00 €
P/E Prévisionnel
46,6
BPA Prévisionnel
0,45 €
Croissance BPA (est.)
+0,0%
CA Est.
1,2 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
2,60 €
2,41 € – 2,72 €
|
1,8 B | 12 |
| FY2029 |
1,91 €
1,77 € – 1,99 €
|
1,7 B | 8 |
| FY2028 |
1,57 €
0,59 € – 2,74 €
|
1,6 B | 14 |
Points Clés
Revenue grew 21,97% annually over 5 years — strong growth
Earnings grew 72,66% over the past year
ROE of 39,89% indicates high profitability
Net margin of 36,49% shows strong profitability
Debt/Equity of 0,04 — conservative balance sheet
Generating 105,15M in free cash flow
Croissance
Revenue Growth (5Y)
21,97%
Revenue (1Y)11,87%
Earnings (1Y)72,66%
FCF Growth (3Y)N/A
Qualité
Return on Equity
39,89%
ROIC6,14%
Net Margin36,49%
Op. Margin9,78%
Sécurité
Debt / Equity
0,04
Current Ratio3,83
Interest Coverage0,00
Valorisation
P/E Ratio
9,15
P/B Ratio2,92
EV/EBITDA32,95
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 11,87% | Revenue Growth (3Y) | 21,45% |
| Earnings Growth (1Y) | 72,66% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 21,97% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,07B | Net Income (TTM) | 391,00M |
| ROE | 39,89% | ROA | 25,00% |
| Gross Margin | 91,69% | Operating Margin | 9,78% |
| Net Margin | 36,49% | Free Cash Flow (TTM) | 105,15M |
| ROIC | 6,14% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,04 | Current Ratio | 3,83 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 9,15 | P/B Ratio | 2,92 |
| P/S Ratio | 3,34 | PEG Ratio | 0,17 |
| EV/EBITDA | 32,95 | Dividend Yield | 0,00% |
| Market Cap | 3,58B | Enterprise Value | 3,45B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,07B | 957,80M | 726,44M | 517,24M | 484,15M |
| Net Income | 391,00M | 226,45M | -61,29M | -215,98M | -167,87M |
| EPS (Diluted) | 2,29 | 1,36 | -0,37 | -1,34 | -1,05 |
| Gross Profit | 982,51M | 875,96M | 680,71M | 507,07M | 465,00M |
| Operating Income | 104,81M | 230,79M | -73,38M | -223,60M | -170,44M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,56B | 1,19B | 748,96M | 587,81M | 700,12M |
| Total Liabilities | 336,81M | 454,96M | 317,20M | 187,40M | 159,23M |
| Shareholders' Equity | 1,23B | 732,79M | 431,76M | 400,41M | 540,89M |
| Total Debt | 52,19M | 52,00M | 57,21M | 62,00M | 64,43M |
| Cash & Equivalents | 177,70M | 319,59M | 188,66M | 114,85M | 147,44M |
| Current Assets | 1,06B | 938,32M | 616,13M | 507,94M | 617,82M |
| Current Liabilities | 277,11M | 394,87M | 254,25M | 125,63M | 96,07M |
Scores de Stratégies
This stock passed the criteria for 4 strategies
Score = fit strength (0–100)
Rank = position among all matches
Activité Récente
Entré
Contrarian Investing (David Dreman)
Mar 24, 2026
Entré
Growth Investing (Philip Fisher)
Mar 24, 2026
Entré
Value Investing (Warren Buffett)
Mar 24, 2026
Entré
Lower Risk
Mar 24, 2026